Skip to main content
Top
Published in: BMC Geriatrics 1/2020

Open Access 01-12-2020 | Geriatric Assessment | Research article

Validation of “(fr)AGILE”: a quick tool to identify multidimensional frailty in the elderly

Authors: Ilaria Liguori, Gennaro Russo, Giulia Bulli, Francesco Curcio, Veronica Flocco, Gianlugi Galizia, David Della-Morte, Gaetano Gargiulo, Gianluca Testa, Francesco Cacciatore, Domenico Bonaduce, Pasquale Abete

Published in: BMC Geriatrics | Issue 1/2020

Login to get access

Abstract

Background

Several tools have been proposed and validated to operationally define frailty. Recently, the Italian Frailty index (IFi), an Italian modified version of Frailty index, has been validated but its use in clinical practice is limited by long time of administration. Therefore, the aim of this study was to create and validate a quick version of the IFi (AGILE).

Methods

Validation study was performed by administering IFi and AGILE, after a Comprehensive Geriatric Assessment (CGA) in 401 subjects aged 65 or over (77 ± 7 years). AGILE was a 10-items tool created starting from the more predictive items of the four domains of frailty investigated by IFi (mental, physical, socioeconomic and nutritional). AGILE scores were stratified in light, moderate and severe frailty. At 24 months of follow-up, death, disability (taking into account an increase in ADL lost ≥1 from the baseline) and hospitalization were considered. Area under curve (AUC) was evaluated for both IFi and AGILE.

Results

Administration time was 9.5 ± 3.8 min for IFi administered after a CGA, and 2.4 ± 1.2 min for AGILE, regardless of CGA (p < 0.001). With increasing degree of frailty, prevalence of mortality increased progressively from 6.5 to 41.8% and from 9.0 to 33.3%, disability from 16.1 to 64.2% and from 22.1 to 59.8% and hospitalization from 17.2 to 58.7% and from 27.0 to 52.2% with AGILE and IFi, respectively (p = NS). Relative Risk for each unit of increase in AGILE was 56, 44 and 24% for mortality, disability and hospitalization, respectively and was lower for IFi (8, 7 and 4% for mortality, disability and hospitalization, respectively). The AUC was higher in AGILE vs. IFi for mortality (0.729 vs. 0.698), disability (0.715 vs. 0.682) and hospitalization (0.645 vs. 0.630).

Conclusions

Our study shows that AGILE is a rapid and effective tool for screening multidimensional frailty, able to predict mortality, disability and hospitalization, especially useful in care settings that require reliable assessment instruments with short administration time.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wleklik M, Uchmanowicz I, Jankowska EA, et al. Multidimensional approach to frailty. Front Psychol. 2020;11:564.CrossRef Wleklik M, Uchmanowicz I, Jankowska EA, et al. Multidimensional approach to frailty. Front Psychol. 2020;11:564.CrossRef
2.
go back to reference Cesari M, Calvani R, Marzetti E. Frailty in older persons. Clin Geriatr Med. 2017;33:293–303.CrossRef Cesari M, Calvani R, Marzetti E. Frailty in older persons. Clin Geriatr Med. 2017;33:293–303.CrossRef
3.
go back to reference Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381:752–62.CrossRef Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381:752–62.CrossRef
4.
go back to reference Morley JE, Vellas B, van Kan GA. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14:392–7.CrossRef Morley JE, Vellas B, van Kan GA. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14:392–7.CrossRef
5.
go back to reference Turner G, Clegg A, British geriatrics society; age UK; Royal College of general Practioners. Best practice guidelines for the management of frailty: a British geriatrics society, age UK and Royal College of general practitioners report. Age Ageing. 2014;43:744–7.CrossRef Turner G, Clegg A, British geriatrics society; age UK; Royal College of general Practioners. Best practice guidelines for the management of frailty: a British geriatrics society, age UK and Royal College of general practitioners report. Age Ageing. 2014;43:744–7.CrossRef
6.
go back to reference Testa G, Liguori I, Curcio F, et al. Multidimensional frailty evaluation in elderly outpatients with chronic heart failure: a prospective study. Eur J Prev Cardiol. 2019;26:1115–7.CrossRef Testa G, Liguori I, Curcio F, et al. Multidimensional frailty evaluation in elderly outpatients with chronic heart failure: a prospective study. Eur J Prev Cardiol. 2019;26:1115–7.CrossRef
7.
go back to reference Hamaker ME, Jonker JM, de Rooij SE, Vos AG, Smorenburg CH, van Munster BC. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol. 2012;13:e437–44.CrossRef Hamaker ME, Jonker JM, de Rooij SE, Vos AG, Smorenburg CH, van Munster BC. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol. 2012;13:e437–44.CrossRef
8.
go back to reference Dent E, Lien C, Lim WS, et al. The Asia-Pacific clinical practice guidelines for the Management of Frailty. J Am Med Dir Assoc. 2017;18:564–75.CrossRef Dent E, Lien C, Lim WS, et al. The Asia-Pacific clinical practice guidelines for the Management of Frailty. J Am Med Dir Assoc. 2017;18:564–75.CrossRef
9.
go back to reference Townend JN, Ludman PF, Doshi SN. Measuring frailty in patients undergoing TAVI: how and why? Eur Heart J. 2019;40:2240–2.CrossRef Townend JN, Ludman PF, Doshi SN. Measuring frailty in patients undergoing TAVI: how and why? Eur Heart J. 2019;40:2240–2.CrossRef
10.
go back to reference Testa G, Curcio F, Liguori I, et al. Physical vs. multidimensional frailty in older adults with and without heart failure. ESC Heart Fail. 2020;7:1371–80.CrossRef Testa G, Curcio F, Liguori I, et al. Physical vs. multidimensional frailty in older adults with and without heart failure. ESC Heart Fail. 2020;7:1371–80.CrossRef
11.
go back to reference Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: a review. Eur J Intern Med. 2016;31:3–10.CrossRef Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: a review. Eur J Intern Med. 2016;31:3–10.CrossRef
12.
go back to reference Fried LP, Tangen CM, Walston J, For cardiovascular health study collaborative research group, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–56.CrossRef Fried LP, Tangen CM, Walston J, For cardiovascular health study collaborative research group, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–56.CrossRef
13.
go back to reference Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62:722–7.CrossRef Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62:722–7.CrossRef
14.
go back to reference Theou O, Brothers TD, Mitnitski A, Rockwood K. Operationalization of frailty using eight commonly used scales and comparison of their ability to predict all-cause mortality. J Am Geriatr Soc. 2013;61:1537–51.CrossRef Theou O, Brothers TD, Mitnitski A, Rockwood K. Operationalization of frailty using eight commonly used scales and comparison of their ability to predict all-cause mortality. J Am Geriatr Soc. 2013;61:1537–51.CrossRef
15.
go back to reference Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. Sci World J. 2001;1:323–36.CrossRef Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. Sci World J. 2001;1:323–36.CrossRef
16.
go back to reference Abete P, Basile C, Bulli G, et al. The Italian version of the "frailty index" based on deficits in health: a validation study. Aging Clin Exp Res. 2017;29:913–26.CrossRef Abete P, Basile C, Bulli G, et al. The Italian version of the "frailty index" based on deficits in health: a validation study. Aging Clin Exp Res. 2017;29:913–26.CrossRef
17.
go back to reference Dent E, Perez-Zepeda M. Comparison of five indices for prediction of adverse outcomes in hospitalized Mexican older adults: a cohort study. Arch Gerontol Geriatr. 2015;60:89–95.CrossRef Dent E, Perez-Zepeda M. Comparison of five indices for prediction of adverse outcomes in hospitalized Mexican older adults: a cohort study. Arch Gerontol Geriatr. 2015;60:89–95.CrossRef
18.
go back to reference Mazzella F, Cacciatore F, Galizia G, et al. Social support and long-term mortality in the elderly: role of comorbidity. Arch Gerontol Geriatr. 2010;51:323–8.CrossRef Mazzella F, Cacciatore F, Galizia G, et al. Social support and long-term mortality in the elderly: role of comorbidity. Arch Gerontol Geriatr. 2010;51:323–8.CrossRef
19.
go back to reference Ungar A, Mussi C, Ceccofiglio A, et al. Etiology of Syncope and unexplained falls in elderly adults with dementia: Syncope and dementia (SYD) study. J Am Geriatr Soc. 2016;64:1567–73.CrossRef Ungar A, Mussi C, Ceccofiglio A, et al. Etiology of Syncope and unexplained falls in elderly adults with dementia: Syncope and dementia (SYD) study. J Am Geriatr Soc. 2016;64:1567–73.CrossRef
20.
go back to reference Lin HM, Williamson JM. A simple approach for sample size calculation for comparing two concordance correlation coefficients estimated on the same subjects. J Biopharm Stat. 2015;25:1145–60.CrossRef Lin HM, Williamson JM. A simple approach for sample size calculation for comparing two concordance correlation coefficients estimated on the same subjects. J Biopharm Stat. 2015;25:1145–60.CrossRef
21.
go back to reference Ensrud KE, Ewing SK, Taylor BC, Fink HA, Stone KL, Cauley JA, et al. Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci. 2007;62:744–51.CrossRef Ensrud KE, Ewing SK, Taylor BC, Fink HA, Stone KL, Cauley JA, et al. Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci. 2007;62:744–51.CrossRef
22.
go back to reference Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging. 2012;16:601–8.CrossRef Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging. 2012;16:601–8.CrossRef
23.
go back to reference Gobbens RJ, van Assen MA, Luijkx KG, Wijnen-Sponselee MT, Schols JM. The Tilburg frailty indicator: psychometric properties. J Am Med Dir Assoc. 2010;11:344–55.CrossRef Gobbens RJ, van Assen MA, Luijkx KG, Wijnen-Sponselee MT, Schols JM. The Tilburg frailty indicator: psychometric properties. J Am Med Dir Assoc. 2010;11:344–55.CrossRef
24.
go back to reference Raiche M, Hebert R, Dubois MF. PRISMA-7: a case-finding tool to identify older adults with moderate to severe disabilities. Arch Gerontol Geriatr. 2008;47:9–18.CrossRef Raiche M, Hebert R, Dubois MF. PRISMA-7: a case-finding tool to identify older adults with moderate to severe disabilities. Arch Gerontol Geriatr. 2008;47:9–18.CrossRef
25.
go back to reference Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394:1365–75.CrossRef Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394:1365–75.CrossRef
26.
go back to reference Marcucci M, Damanti S, Germini F, et al. Interventions to prevent, delay or reverse frailty in older people: a journey towards clinical guidelines. BMC Med. 2019;17:193.CrossRef Marcucci M, Damanti S, Germini F, et al. Interventions to prevent, delay or reverse frailty in older people: a journey towards clinical guidelines. BMC Med. 2019;17:193.CrossRef
27.
go back to reference Negm AM, Kennedy CC, Thabane L, et al. Management of Frailty: a systematic review and network meta-analysis of randomized controlled trials. J Am Med Dir Assoc. 2019;20:1190–8.CrossRef Negm AM, Kennedy CC, Thabane L, et al. Management of Frailty: a systematic review and network meta-analysis of randomized controlled trials. J Am Med Dir Assoc. 2019;20:1190–8.CrossRef
28.
go back to reference Apóstolo J, Cooke R, Bobrowicz-Campos E, et al. Effectiveness of interventions to prevent pre-frailty and frailty progression in older adults: a systematic review [published correction appears in JBI database system rev implement rep. 2018;16:1282-1283]. JBI Database System Rev Implement Rep. 2018;16:140–232.CrossRef Apóstolo J, Cooke R, Bobrowicz-Campos E, et al. Effectiveness of interventions to prevent pre-frailty and frailty progression in older adults: a systematic review [published correction appears in JBI database system rev implement rep. 2018;16:1282-1283]. JBI Database System Rev Implement Rep. 2018;16:140–232.CrossRef
Metadata
Title
Validation of “(fr)AGILE”: a quick tool to identify multidimensional frailty in the elderly
Authors
Ilaria Liguori
Gennaro Russo
Giulia Bulli
Francesco Curcio
Veronica Flocco
Gianlugi Galizia
David Della-Morte
Gaetano Gargiulo
Gianluca Testa
Francesco Cacciatore
Domenico Bonaduce
Pasquale Abete
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2020
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-020-01788-1

Other articles of this Issue 1/2020

BMC Geriatrics 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.